Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients: Complete Statistical AnalysisIndependent statistical analysis of EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients: primary endpoint results, effect estimate with confidence…
- EMPOWERIndependent statistical analysis of Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EMPOWER-MomIndependent statistical analysis of Postpartum Weight Loss for Women at Elevated Cardiovascular Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04914819).
- EMPOWER-T2DIndependent statistical analysis of EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04531176).
- EMTIndependent statistical analysis of Enhanced Community-Based Asthma Monitoring Through Novel Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05824936).
- EnACTIndependent statistical analysis of Developing and Testing the Enhancing Active Caregiver Training (EnACT) Intervention for Dementia Family Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ENACT-aMCIIndependent statistical analysis of ENgaging in Advance Care Planning Talks Group Visit Intervention for Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05282459).
- ENB-GS-TBLB for the Diagnosis of PPLs: Complete Statistical AnalysisIndependent statistical analysis of ENB-GS-TBLB for the Diagnosis of PPLs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02207478).
- Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00778648).
- ENCOREIndependent statistical analysis of A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE): primary endpoint results, effect estimate with confidence…
- ENCOREIndependent statistical analysis of Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ENCOREIndependent statistical analysis of Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ENCORE-VTIndependent statistical analysis of Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ENDEAVORIndependent statistical analysis of the ENDEAVOR phase 3 trial of carfilzomib and dexamethasone versus bortezomib and dexamethasone in relapsed multiple myeloma, including progression-free survival, overall survival, response, safety, and statistical methodology.
- ENDEAVORIndependent statistical analysis of Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle: Complete Statistical AnalysisIndependent statistical analysis of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ENDOMEDEIndependent statistical analysis of Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice Forielle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Endometrial Injury for Unexplained Infertility: Complete Statistical AnalysisIndependent statistical analysis of Endometrial Injury for Unexplained Infertility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02863198).
- EndoRings Colonoscopy vs Standard Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of EndoRings Colonoscopy vs Standard Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03418662).
- Endoscopic Therapy of Early Cancer in Barretts Esophagus: Complete Statistical AnalysisIndependent statistical analysis of Endoscopic Therapy of Early Cancer in Barretts Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00217087).
- EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX: Complete Statistical AnalysisIndependent statistical analysis of EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Endothelial Bleb Response With Toric Lenses: Complete Statistical AnalysisIndependent statistical analysis of Endothelial Bleb Response With Toric Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00630305).
- Endothelial Hyperpolarization in Humans: Complete Statistical AnalysisIndependent statistical analysis of Endothelial Hyperpolarization in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00166166).
- Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: Complete Statistical AnalysisIndependent statistical analysis of Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00583050).
- ENDURANCE-2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection: primary endpoint results, effect estimate with confidence…
- ENDUREIndependent statistical analysis of A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis…
- ENERGIZEIndependent statistical analysis of A Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8: primary endpoint results, effect estimate with confidence interval, sample-size…
- ENESTPathIndependent statistical analysis of A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.: primary endpoint results, effect estimate…
- ENFORCEIndependent statistical analysis of A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ENGAGEIndependent statistical analysis of Engaging Patients in Tobacco Cessation Resources in Dental Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03656874).
- ENGAGE AF-TIMI 48Independent statistical analysis of ENGAGE AF-TIMI 48, evaluating edoxaban versus warfarin for stroke and systemic embolic events in patients with atrial fibrillation.
- Engagement With an Adaptive Mobile Health Smoking Cessation Intervention: Complete Statistical AnalysisIndependent statistical analysis of Engagement With an Adaptive Mobile Health Smoking Cessation Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04020718).
- ENGAGESIndependent statistical analysis of Electroencephalography Guidance of Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02241655).
- ENHANCEIndependent statistical analysis of Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ENHANCE-ITIndependent statistical analysis of Pharmacodynamic Effects of a Free-Fatty Acid Formulation of Omega-3 Pentaenoic Acid in Adults With Hypertriglyceridemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Enhancing Adolescent Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Adolescent Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03249350).
- Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00555360).
- Enhancing Community Capacity to Improve Cancer Care Delivery: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Community Capacity to Improve Cancer Care Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04107116).
- Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01822587).
- Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Enhancing Plasticity in Stroke Patients With Severe Motor Deficit: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Plasticity in Stroke Patients With Severe Motor Deficit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02633215).
- Enhancing Self Regulation as a Strategy for Obesity Prevention in Head Start Preschoolers: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Self Regulation as a Strategy for Obesity Prevention in Head Start Preschoolers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- EnligHTN-IVIndependent statistical analysis of EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ENLIVENIndependent statistical analysis of Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- EnsembleIndependent statistical analysis of Ensemble Programme an Early Intervention for Informal Caregivers of Psychiatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ENSURE-AFA detailed statistical analysis of the ENSURE-AF phase 3 trial comparing edoxaban with warfarin in patients undergoing cardioversion for nonvalvular atrial fibrillation, including endpoint definitions, odds-ratio interpretation, confidence intervals, analysis populations, and…
- Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…